Biomarin Pharmaceutical SG&A Expense (Quarterly) Trends

Biomarin Pharmaceutical Inc (BMRN)

91.65 +2.12 (+2.37%) USD | NASDAQ | Apr 23, 11:35

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1999. Upgrade now.

Date	Value
December 31, 2023	275.00M
September 30, 2023	224.00M
June 30, 2023	215.34M
March 31, 2023	223.00M
December 31, 2022	245.70M
September 30, 2022	216.80M
June 30, 2022	196.84M
March 31, 2022	194.62M
December 31, 2021	217.60M
September 30, 2021	183.30M
June 30, 2021	184.20M
March 31, 2021	174.30M
December 31, 2020	195.50M
September 30, 2020	179.50M
June 30, 2020	175.40M
March 31, 2020	187.30M
December 31, 2019	187.88M
September 30, 2019	170.11M
June 30, 2019	160.70M
March 31, 2019	162.16M
December 31, 2018	164.22M
September 30, 2018	148.57M
June 30, 2018	153.28M
March 31, 2018	138.34M
December 31, 2017	160.28M

Date	Value
September 30, 2017	130.53M
June 30, 2017	143.50M
March 31, 2017	120.02M
December 31, 2016	142.96M
September 30, 2016	118.76M
June 30, 2016	109.58M
March 31, 2016	105.30M
December 31, 2015	113.91M
September 30, 2015	94.04M
June 30, 2015	101.51M
March 31, 2015	92.81M
December 31, 2014	99.77M
September 30, 2014	74.60M
June 30, 2014	68.09M
March 31, 2014	60.07M
December 31, 2013	71.81M
September 30, 2013	61.84M
June 30, 2013	50.66M
March 31, 2013	51.05M
December 31, 2012	55.05M
September 30, 2012	46.34M
June 30, 2012	51.54M
March 31, 2012	45.25M
December 31, 2011	48.45M
September 30, 2011	44.88M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

160.70M

Minimum

Jun 2019

275.00M

Maximum

Dec 2023

200.37M

Average

194.62M

Median

Mar 2022

SG&A Expense (Quarterly) Benchmarks